Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor - Gómara, M.J.; Sánchez-Merino, V.; Paús, A.; Merino-Mansilla, A.; Gatell, J.M.; Yuste, E.; Haro, I. (Biochimica et biophysica acta, 2016)
Keywords: Amino Acid Sequence; Anti-HIV Agents - pharmacology; antiretroviral agents; antiviral properties; E1 protein; energy transfer; entry inhibitor; enzyme-linked immunosorbent assay; fluorescence; fusion peptide; GB virus C; hemolysis; Hepatitis GB virus B; HIV-1; HIV-1 - drug effects; HIV-1 - physiology; Human immunodeficiency virus 1; Molecular Sequence Data; mortality; Peptide Fragments - pharmacology; peptide libraries; synthetic peptide; synthetic peptides; Viral Envelope Proteins - pharmacology; viremia; Virus Internalization - drug effects; viruses; HIV-1; fusion peptide; OPD; FP; HT; NBD; POPG; GBV-C; Rho; HATU; Dbz; synthetic peptide; entry inhibitor; DIPEA; MPAA; Nbz; Pmc; GB virus C; Acm; ACN; LUV; mAb; SEC; E1 protein; MPER; NCL; VIRIP; VSV; HB; TCEP; DHB; HAART; TIS